New gut bacteria therapy shows promise for colitis
Disease control
Completed
This early-stage study tested a new treatment called MB310 in 29 adults with mild-to-moderate ulcerative colitis. The main goal was to see if it is safe and how well it takes hold in the body. Participants received either MB310 or a placebo, and researchers monitored side effects…
Phase: PHASE1 • Sponsor: Microbiotica Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC